Trex Company Inc <TREX.N>: BMO Raises Target Price To $56 From $54
TREX•Related News
Most brokerages see Fed on hold, but hawkish view grows
SPY•
Lantern Pharma To Advance EMA-Cleared Phase 1B/2 Trial Of Lp-184 (Zirdafulven) In Biomarker-Selected Advanced Bladder Cancer
LTRN•
Brazil posts narrower-than-expected current account deficit in June
EWZ•
S&P Global posts Q2 earnings release, supplemental materials on investor site
SPGI•
Tonix Pharmaceuticals posts investor deck focused on TONMYA fibromyalgia launch and pipeline updates
TNXP•